Online Media Kit

FEATURED STORY

January 26, 2021 | World Health Organization

WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection

WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »

FEATURED STORY

November 30, 2020 | New York Times

Berry-Flavored H.I.V. Medication Is Ready for Babies

The World Health Organization approved the dapivirine ring, a vaginal insert that has proved effective in women who use it consistently. Finding prevention methods that women can use discreetly has... More »

FEATURED STORY

July 30, 2020 | Aidsmap (UK)

The vaginal ring against HIV: regulatory approval for a new prevention choice for women

The dapivirine ring is the first HIV prevention option specifically designed for women since the female condom was approved nearly 30 years ago. More »

FEATURED STORY

July 24, 2020 | Times LIVE (South Africa)

Vaginal ring gives women more options for HIV prevention

Access to a long-acting vaginal ring, which was tested in SA and showed promising results, is getting closer to reality after Europe’s regulatory body gave it the thumbs-up. More »

Media Highlights

July 28, 2020 | ZTN News (Zimbabwe)

Dapivirine Ring Provides Safe Sex For Women

The ring is inserted into the vagina and lasts for 28 days, providing protection against HIV. However, it does not protect one from sexually transmitted infections and pregnancy. More »

July 28, 2020 | UNAIDS

UNAIDS is hopeful that a new long-acting HIV prevention option will soon become available for women in sub-Saharan Africa

UNAIDS congratulates IPM on obtaining a positive opinion from the EMA on the dapivirine vaginal ring. The monthly ring adapts a medical technology commonly used as a contraceptive device to deliver... More »

July 28, 2020 | Life4me+ (Germany)

EMA empfiehlt Dapivirin-Vaginalring zum Schutz vor HIV

The EMA recommends approval for women over the age of 18 in combination with other safer sex practices. More »

July 28, 2020 | Deutsche Apotheker Zeitung (DAZ) (Germany)

Dapivirin-Vaginalring zum Schutz vor HIV-1

The CHMP advises that a dapivirine vaginal ring be approved in countries outside the EU. TThe ring is said to have reduced the infection rate by 35 percent in studies. More »

Pages